ArticleThe Journal of experimental medicine2024

Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage.

Ann-Jay Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.